Delta sleep inducing peptide (DSIP): effect on respiration activity in rat brain mitochondria and stress protective potency under experimental hypoxia.
Neuromodulatory delta sleep inducing peptide (DSIP) seems to be implicated in the attenuation of stress-induced pathological metabolic disturbances in various animal species and human beings. Mitochondria, as cell organelles, are considered especially sensitive to stress conditions. In this work, the influence of DSIP and Deltaran((R))-a recently developed product based upon DSIP-on processes of oxidative phosphorylation and ATP production in rat brain mitochondria and rat brain homogenates was studied. A polarographic measurement of oxygen consumption was applied to evaluate the impact of DSIP on maximal rates of mitochondrial respiration and coupling of respiration to ATP production. We provide evidence that DSIP affected the efficiency of oxidative phosphorylation on isolated rat brain mitochondria. This peptide significantly increased the rate of phosphorylated respiration V3, while the rate of uncoupled respiration V(DNP) remaining unchanged. It enhanced the respiratory control ratio RCR and the rate of ADP phosphorylation. DSIP and Deltaran exhibited the same action in rat brain homogenates. We also examined the influence of DSIP under hypoxia when mitochondrial respiratory activity is altered. In rats subjected to hypoxia, we detected a significant stress-mediated reduction of V3 and ADP/t values. Pretreatment of rats with DSIP at the dose of 120 microgram/kg (i.p.) prior to their subjection to hypoxia completely inhibited hypoxia-induced reduction of mitochondrial respiratory activity. The revealed capacity of DSIP to enhance the efficiency of oxidative phosphorylation found in vitro experiments could contribute to understanding pronounced stress protective and antioxidant action of this peptide in vivo.
Khvatova
Elena M
EM
Nizhnii Novgorod Medical Academy, Minina-Pozharskogo 10/1, 603005, Nizhnii Novgorod, Russia.
Samartzev
Victor N
VN
Zagoskin
Pavel P
PP
Prudchenko
Igor A
IA
Mikhaleva
Inessa I
II
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000502:physiology; D003701:Delta Sleep-Inducing Peptide / Q000494:pharmacology*; D004579:Electron Transport / Q000187:drug effects; D005998:Glycine / Q000494:pharmacology*; D000860:Hypoxia / Q000503:physiopathology; D008297:Male; D008928:Mitochondria / Q000187:drug effects* / Q000502:physiology; D010085:Oxidative Phosphorylation / Q000187:drug effects; D051381:Rats; D013312:Stress, Physiological / Q000503:physiopathology
C480301:Deltran; D003701:Delta Sleep-Inducing Peptide; D005998:Glycine